Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Her2 Positive Metastatic Breast Cancer × Lapatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Glioblastoma 2 Squamous Cell Carcinoma of Head and Neck 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neoplasm Metastasis 1 Medulloblastoma 1 Inflammatory Breast Neoplasms 1 Her2 Positive Metastatic Breast Cancer 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Familial ependymoma 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Lapatinib 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01495884 2015-10-26

The Myocet/Lapatinib Study. ICORG 10-03, V5

Cancer Trials Ireland

Phase 1/2 Terminated

Her2 Positive Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡